Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer

Recruiting now

Conditions studied: Lung Neoplasm

In brief

Create a living biobank of PDOs from Stage I-III lung cancer patients.

Key facts

Study ID

NCT03655015

Run by

The University of Texas Health Science Center at San Antonio

People needed

150

Starts

2018-10-16

Expected to finish

2029-12-01

Last updated by the study team

2026-04-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Read, consented to and signed the IRB-approved informed consent form prior to any study related procedure.
• Diagnosis of lung cancer or lung mass or lymphadenopathy that will either systemic treatment or tumor resection as part of standard of care
• Any clinical stage of lung cancer
• Adult patients ≥18 years of age
• Able and willing to complete a questionnaire on their environmental/occupational exposures and smoking/alcohol history

You may not qualify if…

• At the discretion of the treating physician, patient will not be able to fulfill the requirements of the study.

Where it is running

• UT Health San Antonio, M.D. Anderson Cancer Center — San Antonio, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.